Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.39M | -104.56M | -130.77M | -121.00M | -192.52M |
| Total Depreciation and Amortization | 56.56M | 58.54M | 60.47M | 60.27M | 58.86M |
| Total Amortization of Deferred Charges | 802.00K | 802.00K | 802.00K | 1.06M | 1.41M |
| Total Other Non-Cash Items | 16.13M | 25.00M | 19.91M | 9.23M | 112.60M |
| Change in Net Operating Assets | -21.37M | -19.30M | -7.98M | 1.01M | -1.51M |
| Cash from Operations | -25.26M | -39.52M | -57.57M | -49.44M | -21.16M |
| Capital Expenditure | -9.85M | -12.35M | -12.42M | -16.15M | -21.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -362.00K | -18.99M | -18.99M | -18.99M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 918.00K | 550.00K |
| Cash from Investing | -9.85M | -12.71M | -31.41M | -34.22M | -40.26M |
| Total Debt Issued | 150.00M | -- | -- | -- | -- |
| Total Debt Repaid | -296.59M | -55.07M | -5.07M | -234.14M | -234.10M |
| Issuance of Common Stock | 4.72M | 4.72M | 4.72M | 1.59M | 1.48M |
| Repurchase of Common Stock | -5.94M | -4.72M | -4.72M | -4.72M | -4.74M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.46M | -11.76M | -11.43M | -13.60M | -4.46M |
| Cash from Financing | -164.27M | -66.83M | -16.50M | -250.87M | -241.81M |
| Foreign Exchange rate Adjustments | 53.00K | -75.00K | -32.00K | -46.00K | -38.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.33M | -119.13M | -105.51M | -334.58M | -303.26M |